Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanlin Shen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chinese Medical Journal|June 10, 2026
Advances in vascularized organoidsLanlin Shen, Jinhu Ma, Xiao Wei, et al.
Redox Biology|May 29, 2019
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancerMin Wang, Yijue Xue, Lanlin Shen, et al.
Oncology Letters|May 28, 2026
Jaceosidin inhibits cell viability and induces apoptosis in non-small cell lung cancer by inhibiting the Ras/Raf/MEK/ERK and Akt pathwaysXiaodie Cao, Chong Ma, Xin Wang, et al.
Oncology Reports|March 22, 2019
Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylationZhen Xiao, Yingying He, Chongya Liu, et al.
Ebiomedicine|March 23, 2019
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancerJingyan Yi, Chongya Liu, Zhiwei Tao, et al.
Molecular Therapy Oncolytics|December 13, 2021
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironmentGang Shi, Pengyi Shi, Yan Yu, et al.
Cell Death & Disease|January 8, 2021
BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor CYuan Zhang, Xiang Gao, Jingyan Yi, et al.
Biomaterials|November 15, 2024
A 3D-printed microdevice encapsulates vascularized islets composed of iPSC-derived β-like cells and microvascular fragments for type 1 diabetes treatmentShuang Chen, Wenshuang Wang, Lanlin Shen, et al.
ACS Applied Materials & Interfaces|May 11, 2022
3D Printing Mini-Capsule Device for Islet Delivery to Treat Type 1 DiabetesShuang Chen, Jing Luo, Lanlin Shen, et al.
Cancer Letters|October 14, 2018
Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERαJinlei Ding, Xiaonan Wang, Yuan Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chinese Medical Journal|June 10, 2026
Advances in vascularized organoidsLanlin Shen, Jinhu Ma, Xiao Wei, et al.
Redox Biology|May 29, 2019
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancerMin Wang, Yijue Xue, Lanlin Shen, et al.
Oncology Letters|May 28, 2026
Jaceosidin inhibits cell viability and induces apoptosis in non-small cell lung cancer by inhibiting the Ras/Raf/MEK/ERK and Akt pathwaysXiaodie Cao, Chong Ma, Xin Wang, et al.
Oncology Reports|March 22, 2019
Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylationZhen Xiao, Yingying He, Chongya Liu, et al.
Ebiomedicine|March 23, 2019
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancerJingyan Yi, Chongya Liu, Zhiwei Tao, et al.
Molecular Therapy Oncolytics|December 13, 2021
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironmentGang Shi, Pengyi Shi, Yan Yu, et al.
Cell Death & Disease|January 8, 2021
BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor CYuan Zhang, Xiang Gao, Jingyan Yi, et al.
Biomaterials|November 15, 2024
A 3D-printed microdevice encapsulates vascularized islets composed of iPSC-derived β-like cells and microvascular fragments for type 1 diabetes treatmentShuang Chen, Wenshuang Wang, Lanlin Shen, et al.
ACS Applied Materials & Interfaces|May 11, 2022
3D Printing Mini-Capsule Device for Islet Delivery to Treat Type 1 DiabetesShuang Chen, Jing Luo, Lanlin Shen, et al.
Cancer Letters|October 14, 2018
Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERαJinlei Ding, Xiaonan Wang, Yuan Zhang, et al.
Pageof 1